On Demand Treatment of Reflux Disease
Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.
1 other identifier
interventional
82
1 country
9
Brief Summary
A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Aug 2002
Typical duration for phase_4
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 15, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedAugust 9, 2011
September 1, 2005
2.3 years
September 15, 2005
August 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptomatic relief
Secondary Outcomes (1)
Overall satisfaction
Study Arms (2)
Aflurax
EXPERIMENTALpectin-containing natural product
esomeprazole (Nexium)
ACTIVE COMPARATOResomeprazole (Nexium)
Interventions
Eligibility Criteria
You may qualify if:
- Mild and moderate reflux symptoms Age \> 17 years Informed consent -
You may not qualify if:
- Other conditions that might explain the symptoms Abuse of drugs or alcohol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- Ferrosan AScollaborator
Study Sites (9)
Gjøvik Specialist Centre
Gjøvik, 2800, Norway
Sykehuset Innlandet HF, Gjøvik
Gjøvik, 2819, Norway
Sykehuset Innlandet HF, Hamar
Hamar, Norway
Sykehuset Innlandet HF, Kongsvinger
Kongsvinger, Norway
Sykehuset Innlandet HF, Lillehammer
Lillehammer, Norway
Helse Nord-Møre og Romsdal
Molde, Norway
Mosjøen sykehus
Mosjøen, Norway
Helse Nord-Trøndelag
Namsos, Norway
Sykehuset Innlandet HF, Tynset
Tynset, Norway
Related Publications (1)
Farup PG, Heibert M, Hoeg V. Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial. BMC Complement Altern Med. 2009 Feb 24;9:3. doi: 10.1186/1472-6882-9-3.
PMID: 19236727RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Per G Farup, PhD
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 15, 2005
First Posted
September 16, 2005
Study Start
August 1, 2002
Primary Completion
November 1, 2004
Study Completion
December 1, 2004
Last Updated
August 9, 2011
Record last verified: 2005-09